Built on 12 years
of real-world MedTech
Dr. Abel Swaan is an independent MedTech consultant with over twelve years of hands-on experience spanning clinical research, regulatory inspection, and C-level product leadership. Trained as a Technical Physician at the University of Twente and holding a PhD from the University of Amsterdam's Faculty of Medicine, he combines rare depth across three domains that most consultants cover only one of: clinical science, regulatory strategy, and medical device development.
Under DRSWN he offers two distinct services: Clinical Evaluations for regulatory approval — producing Clinical Evaluation Reports (CERs), clinical development plans, and supporting EU MDR and FDA submissions for medical device companies across Europe and beyond — and C-Level MedTech interim leadership, stepping in as CTO, CMO, or interim director when companies need experienced hands at the helm during pivotal moments. His inspector background at the Dutch Health & Youth Care Inspectorate (IGJ) means he has sat on both sides of the regulatory table, giving clients a practical edge that purely academic or purely industry consultants cannot replicate.
Registered in the Dutch BIG-register as a Technical Physician under Article 36a — one of the Netherlands' most demanding clinical-technical credentials — Dr. Swaan's six years of doctoral research at Amsterdam UMC produced 10+ peer-reviewed publications in journals including Journal of Biophotonics, Lasers in Surgery and Medicine, and Technology in Cancer Research & Treatment. As Senior Inspector at the Dutch Health & Youth Care Inspectorate (IGJ) from 2020 to 2022, he led MDR compliance audits, market-introduction monitoring, and post-market surveillance oversight — giving him a perspective that is exceptionally rare among independent MedTech consultants.